Clusterin in Alzheimer's disease: mechanisms, genetics, and lessons from other pathologies

EM Foster, A Dangla-Valls, S Lovestone… - Frontiers in …, 2019 - frontiersin.org
Clusterin (CLU) or APOJ is a multifunctional glycoprotein that has been implicated in several
physiological and pathological states, including Alzheimer's disease (AD). With a prominent …

[HTML][HTML] Inflammation, extracellular matrix remodeling, and proteostasis in tumor microenvironment

M Marozzi, A Parnigoni, A Negri, M Viola… - International journal of …, 2021 - mdpi.com
Cancer is a multifaceted and complex pathology characterized by uncontrolled cell
proliferation and decreased apoptosis. Most cancers are recognized by an inflammatory …

Single-cell characterization of malignant phenotypes and developmental trajectories of adrenal neuroblastoma

R Dong, R Yang, Y Zhan, HD Lai, CJ Ye, XY Yao… - Cancer Cell, 2020 - cell.com
Neuroblastoma (NB), which is a subtype of neural-crest-derived malignancy, is the most
common extracranial solid tumor occurring in childhood. Despite extensive research, the …

Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1

NW Mabe, M Huang, GN Dalton, G Alexe, DA Schaefer… - Nature cancer, 2022 - nature.com
Immunotherapy with anti-GD2 antibodies has advanced the treatment of children with high-
risk neuroblastoma, but nearly half of patients relapse, and little is known about mechanisms …

An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED

W Qi, K Zhao, J Gu, Y Huang, Y Wang, H Zhang… - Nature chemical …, 2017 - nature.com
Abstract Polycomb repressive complex 2 (PRC2) consists of three core subunits, EZH2, EED
and SUZ12, and plays pivotal roles in transcriptional regulation. The catalytic subunit EZH2 …

Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma

R Zeid, MA Lawlor, E Poon, JM Reyes, M Fulciniti… - Nature …, 2018 - nature.com
Amplification of the locus encoding the oncogenic transcription factor MYCN is a defining
feature of high-risk neuroblastoma. Here we present the first dynamic chromatin and …

Targeted disruption of the EZH2–EED complex inhibits EZH2-dependent cancer

W Kim, GH Bird, T Neff, G Guo, MA Kerenyi… - Nature chemical …, 2013 - nature.com
Enhancer of zeste homolog 2 (EZH2) is the histone lysine N-methyltransferase component
of the Polycomb repressive complex 2 (PRC2), which, in conjunction with embryonic …

Origin and initiation mechanisms of neuroblastoma

S Tsubota, K Kadomatsu - Cell and tissue research, 2018 - Springer
Neuroblastoma is an embryonal malignancy that affects normal development of the adrenal
medulla and paravertebral sympathetic ganglia in early childhood. Extensive studies have …

[HTML][HTML] Regulation and role of EZH2 in cancer

H Yamaguchi, MC Hung - Cancer research and treatment …, 2014 - synapse.koreamed.org
Abstract Polycomb repressive complex 2 (PRC2) is the epigenetic regulator that induces
histone H3 lysine 27 methylation (H3K27me3) and silences specific gene transcription …